HKU Invents Antibacterial Nano-Sheet Treatment for MRSA Bone Marrow Infection With 99.72 Percent Effectiveness

HKU Invents Antibacterial Nano-Sheet Treatment for MRSA Bone Marrow Infection With 99.72 Percent Effectiveness
The University of Hong Kong School of Medicine has developed a two-dimensional sensitizer nano-sheet that can eliminate MRSA bone marrow infection. Courtesy of University of Hong Kong
Updated:
0:00
The School of Medicine of the University of Hong Kong (HKU) has invented two-dimensional novel antibacterial nano-sheets which can eliminate more than 99.72 percent of methicillin-resistant Staphylococcus aureus (MRSA) in bone tissue.
The study results have been published in Advanced Materials.
Spring Lin
Spring Lin
Author
Spring Lin is a reporter based in Japan. He has written on health topics for The Epoch Times since 2022, mainly focusing on Integrative Medicine.
Related Topics